Drugs / N-3C01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07639450 | Jun 2026 → Aug 2028 expected | cancer | Hefei Xinzhu Biological Technology Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N-3C01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07639450 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT07639450 ↗ |